R&D Systems代理6087-EN-010 Recombinant Human CD39L1/ENTPD2 Protein, CF (10 UG)

2025-06-27

货号:6087-EN-010

品牌:R&D Systems

规格:10ug

目录价:¥4490.00

市场价格:¥3592.00

会员价格:¥3592.00

  • 到货时间:3~4周

    金山科研平台,产品价格货期咨询微信:jinshanbio Source:Chinese Hamster Ovary cell line, CHO-derived, Thr29-Asp460, with a C-terminal 6-His tag Accession #:Q9Y5L3 N-terminal Sequence Analysis:Thr29 Structure:Monomer Purity:>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. Endotoxin Level: Predicted Molecular Mass:48 kDa SDS-PAGE:60-70kDa, reducing conditions Activity:Measured by its ability to hydrolyze the 5’-phosphate groups from the substrate adenosine-5’-triphosphate (ATP). The orthophosphate product is measured by a Malachite Green Phosphate Detection Kit (Catalog# DY996).The specific activity is >5,000 pmol/min/µg, as measured under the described conditions. Formulation:Supplied as a 0.2 µm filtered solution in Tris, NaCl, CaCl2 and Glycerol.See Certificate of Analysis for details. Molecule Information: CD39L1/ENTPD2 Long Name: Ecto-Nucleoside Triphosphate Diphosphohydrolase 2 Aliases: CD39L1; Ecto-ATPase; ENTPD2; NTPD2; NTPDase 2 Entrez Gene IDs: 954 (Human); 12496 (Mouse) Background: CD39L1 CD39L1, also known as ENTPD2 and NTPDase2, is an ectonucleotidase belonging to the CD39 family. It is found on the surface of vascular adventitial cells and accessory vascular cells. CD39L1 is a Ca2+ and Mg2+ dependent enzyme that activates platelets by preferentially converting ATP to ADP. CD39L1 plays a role in regulating thrombosis and inflammation. It is considered to be a therapeutic target for thromboregulation and the treatment of vascular inflammation.

    © 金山科研平台是专业的授权总代理区域代理经销平台。
    © 如需询价,请加客服QQ:1749072012 、客服微信:jinshanbio,或发送邮件到1749072012@qq.com
    © 平台为生命科学研究相关领域提供一站式耗材试剂仪器解决方案和采购服务,数据资源基于CC协议。
    © 本文地址:https://www.16ao.com/thread-137419.htm
    © R&D Systems代理6087-EN-010 Recombinant Human CD39L1/ENTPD2 Protein, CF (10 UG),产品报价联系微信jinshanbio
  • 产品询价需求提交
    产品询价请加微信:jinshanbio
    返回